Price Alert

Core Laboratories N.V. (CLB)

NYSE: CLB · Real-Time Price · USD

10.61

-0.13 (-1.21%)

At close: Aug 14, 2025, 3:59 PM

10.60

-0.09%

Pre-market: Aug 15, 2025, 08:45 AM EDT

Core Laboratories Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Revenue	517.38M	517.8M	523.85M	522.82M	513.77M	511.07M	509.79M	509.15M	509.77M	502.79M	489.74M	487.3M	479.32M	477.17M	470.25M	458.86M	446.26M	443.25M
Cost of Revenue	430.9M	430.23M	435.48M	431M	421.07M	418.6M	415.74M	414.24M	416.79M	414.88M	410.82M	408.31M	402.63M	398.9M	386.41M	377.78M	366.57M	364.08M
Gross Profit	86.48M	87.57M	88.37M	91.82M	92.7M	92.47M	94.05M	94.91M	92.98M	87.91M	78.92M	78.99M	76.7M	78.27M	83.84M	81.08M	79.69M	79.17M
Operating Income	53.69M	54.4M	58.56M	58.96M	53.83M	55.99M	53.9M	54.94M	54.91M	48.4M	41.52M	40.11M	32.1M	33.25M	45.26M	54.47M	59.16M	43.79M
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	42.63M	42.85M	46.19M	45.6M	40.44M	43.31M	41.21M	42.78M	42.77M	36.04M	29.95M	29.03M	21.49M	22.82M	36.11M	44.98M	47.67M	31.47M
Net Income	29.63M	28.03M	31.4M	26.2M	23.71M	37.52M	36.67M	41.23M	39.49M	23.71M	19.5M	15.44M	8.79M	9.78M	19.73M	30.58M	32.66M	18.89M
Selling & General & Admin	41.52M	41.31M	39.46M	38.67M	39.46M	35.01M	39.55M	39.98M	40.87M	41.9M	38.12M	40.32M	45.43M	48.26M	44.17M	29.55M	23.38M	22.93M
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	-5.76M	-8.15M	-9.64M	-5.81M	-589K	2.13M	1.26M	651K	-2.14M	-2.47M	-2.44M	-1.78M	n/a	n/a	n/a	n/a	1.61M	-1.07M
Operating Expenses	35.76M	33.16M	29.82M	32.85M	38.87M	36.48M	40.15M	39.97M	38.07M	39.43M	35.68M	38.54M	45.43M	48.26M	44.17M	29.55M	22.29M	24.88M
Interest Expense	11.05M	11.55M	12.37M	13.36M	13.4M	13.42M	13.43M	12.89M	12.88M	12.36M	11.57M	11.08M	10.61M	10.43M	9.15M	9.48M	11.48M	12.32M
Selling & Marketing Expenses	n/a	-287K	3K	-370K	-706K	-89K	-379K	-6K	330K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	466.66M	463.39M	465.29M	464.29M	460.36M	455.51M	456.31M	454.21M	454.86M	454.31M	446.49M	446.85M	448.06M	447.16M	430.58M	407.34M	388.86M	388.97M
Income Tax Expense	12.42M	14.12M	14.03M	18.49M	16.1M	5.23M	4.18M	1.5M	3.05M	12.1M	10.3M	13.27M	12.38M	12.64M	15.89M	13.61M	14.31M	11.99M
Shares Outstanding (Basic)	47.51M	46.77M	46.83M	46.92M	46.91M	46.86M	46.86M	46.69M	46.67M	46.63M	46.36M	46.34M	46.32M	46.3M	46.35M	46.29M	46.32M	45.18M
Shares Outstanding (Diluted)	47.51M	46.77M	47.77M	47.82M	47.74M	47.7M	47.56M	47.6M	47.5M	47.48M	46.83M	47.01M	47.14M	46.3M	46.93M	47.13M	47.1M	45.96M
EPS (Basic)	0.63	0.60	0.67	0.55	0.50	0.80	0.79	0.89	0.85	0.51	0.42	0.33	0.19	0.21	0.43	0.67	0.72	0.42
EPS (Diluted)	0.63	0.60	0.67	0.56	0.50	0.79	0.77	0.86	0.83	0.50	0.41	0.33	0.19	0.21	0.43	0.67	0.72	0.42
EBITDA	72.06M	69.19M	73.51M	74.13M	69.25M	71.58M	69.69M	70.92M	71.14M	60.68M	54.33M	53.23M	45.55M	46.7M	59.03M	68.67M	74.03M	64.09M
EBIT	53.69M	54.4M	58.56M	58.96M	53.83M	56.15M	54.06M	55.1M	55.07M	50.33M	43.46M	42.04M	34.04M	35.9M	47.91M	57.12M	61.81M	43.79M
Depreciation & Amortization	18.44M	14.83M	14.95M	15.16M	15.42M	15.58M	15.78M	15.98M	16.23M	23.83M	24.35M	24.67M	25M	25.35M	25.66M	26.1M	26.77M	20.3M